We have made strong investments in the cannabis Industry in order to deliver value to our shareholders

Why Cannabis?

Recreational and medical cannabis is a robust and growing multi-billion dollar industry.
Captor plans to make significant investments for both long term capital appreciation and
short term gains in this sector.

Production

Cultivation

Cultivation is the growing and harvesting of the cannabis plant. By investing in high technology production facilities Captor can ensure the quality, safety, and supply of its recreational and medical cannabis products.

Extraction

Extraction

Cannabis extraction relates to the refining of the raw plant to produce speciality products such as medicine to be used by patients.

Retail

Distribution

Captor is highly focused on expanding its holding of retail dispensaries across the USA.

Investment Current

I-5 Holdings Ltd. produces and processes cannabis related products. It offers marijuana edibles, topicals, tinctures, concentrates, and pharmaceutical grade cannabis vape oils.

The company provides its products for recreational and pharmaceutical purpose. It was formerly known as I-5 Cannabis Holdings Ltd. I-5 Holdings Ltd. was founded in 2005 and is based in Vancouver, Canada. As of February 26, 2018, I-5 Holdings Ltd. operates as a subsidiary of Captor Capital Corp.

Investment Current

Founded in 2005

I-5 Holdings Ltd.
#410–885 Dunsmuir St,
Vancouver V6C 1N5, Canada
Phone: +1 604-688-9588
Website: i-5holdingsltd.com

Press Releases

Toronto, Ontario – Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; USOTC:NWURF FRANKFURT:NMV) today resumed trading on the Canadian Securities Exchange as a cannabis focused investment company. The Company is pleased to provide a comprehensive update on the Company’s strategy, leadership, and investments and report a significant amount of progress during its halted period.

Retail Opportunities
Continuing the focus on the California retail market, Captor, through its wholly owned U.S. subsidiary, yesterday acquired a third California dispensary in Santa Cruz for USD$6.1 in cash, Capitola Healing Association (Chai Cannabis Inc., "Chai"). According to the dispensary’s unaudited financial statements, it had average annual revenues of approximately USD$10 million over the last three years. Captor will be seeking to grow Chai’s sales through the addition of a delivery license and doubling its sales floor space.

Additionally, Captor is currently in the process of negotiating and documenting the acquisition of two additional retail dispensaries, one in Monterey Bay, CA and one in Silicon Beach, CA. Upon completion of these acquisitions, Captor will hold a total of five retail cannabis dispensaries in California and will have positioned itself to become a dominant player in the California retail cannabis market.

Captor has seen growth in both Medmen locations in Southern California throughout 2018. Revenue in the first quarter of 2018, following recreational legalization were up several hundred percent for both of Captor’s MedMen dispensary locations.

Captor’s West Hollywood MedMen branded dispensary achieved approximately $6.4 million USD in revenue in Q1 2018, and the store is expected to reach approximately the same level sales in Q2 of 2018. Captor’s Santa Ana MedMen branded dispensary achieved approximately $1.1 million USD in revenue in Q1 of 2018 and management expects revenue to increase in the second quarter of 2018.

Manufacturing Opportunities
Captor is in the final stages of negotiation and documentation of terms with Mellow Extracts, LLC. Mellow will own and operate in a state-of-the-art extraction lab facility in Costa Mesa, California. The facility has been completed and awaiting final inspections. Mellow will produce ultra-premium oil and provide service-for-hire extraction, as well as co-packing capacities for white label and private label cannabis brands focusing on cannabis extracts., In addition to this Mellow will provide oils and premium concentrates to Captor’s retail outlets. Mellow has carved out a unique position as a supply chain partner between distributors and brands. With a committed book of business averaging $500,000 USD in monthly sales. Mellow has a strong platform from which to grow in this expanding sector. Through selectively working with leading brands, Mellow is positioned to become a major player in the market. In addition Mellow currently has applications for three licenses in San Diego in conjunction with a local partner.

Cultivation Opportunities
Our wholly owned subsidiary (I-5 Holdings) has two cultivation operations in the state of Washington. Both are operating tier 2 licenses under their allowed 10,000 sq ft of cultivation space. The acquisition of and investments inin these cultivation assets has resulted in revenue of approximately $100,000 USD per month from its cultivation operations. I-5 will continue to build out both facilities to their full potential of 10,000 sq ft of cultivation canopy.

Overall Outlook
Captor has shifted its focus to investments in the US cannabis market and has been rewarded for the partnerships it has founded and investments it has made. Throughout the rest of 2018 Captor will look to acquire/ invest in additional retail opportunities in California to expand its portfolio of assets with a significant pipeline. As Captor continues to expand it will look to create a brand of quality that will be recognizable across the state that customers will come to trust.

Captor Investment Strategy
Through partnership with top brands, such as MedMen, high value dispensary locations and cultivation operations, Captor seeks to capitalize upon the combination of its intellectual property and extensive network of industry relationships to provide its customers with a wide variety of products and a best in class experience. The primary strategic focus of Captor is to acquire profitable, established cannabis focused companies that require capital to scale. To efficiently engage Captor’s well-defined and deep pipeline of cultivation and dispensary targets, the Company will acquire them at favorable prices, and unlock the intrinsic value of these firms through operational enhancements.

Target investments will be top quality operations with experienced management and defined business plans. Acquisitions will be selected based off of synergy, possibly with current existing brands, locations, and operations. Upon acquisition the investments will be integrated and supported to enhance operations and profitability. With an initial focus on the high value markets of California and Nevada, Captor is building a team of experienced operators designed to support organic growth. Captor will continue to expand its geographic footprint as the industry evolves legally within the USA, and potentially internationally, depending on the regulatory framework.

In addition to developing its robust pipeline and completing key acquisitions, Captor has significantly added to its management team which comprises a mix of leading entrepreneurs, banking and corporate professionals and cannabis operators. Captor will continue to add to its management team and operational team as the company accelerates its growth.


Captor Leadership

John Zorbas - CEO
Mr. John Zorbas is an entrepreneur with a proven track record in the exploration, development industry and the investment banking specifically in the hospitality and retail industry. He has held senior advisory positions in various facets of business including operations, marketing, sales, strategic planning and structured finance. Has directly completed over 2 billion dollars in structured financing and Merger and Acquisitions.

John MacPhail - Founder and CEO of I-5 Holdings Ltd (Subsidiary of Captor)
Mr. John MacPhail is most recently the founder and CEO of I-5 Holdings Ltd. and sits on the board of Mainstem Goods & Services. I-5 Holdings Ltd. is a Canadian cannabis company focused on the USA sector. Mr. Macphail has been actively involved in the Cannabis sector for the past 3 years. Under his leadership the company aquired two dispensaries in California, partnered with two cultivators in Washington state, created growth in a goods and services procurement company, and assisted in the opening of a laboratory in California.

Matt Longo - Director of Manufacturing & Cultivation
Mr. Matt Longo has over 15 years operating experience in the cannabis industry and has extensive agricultural and supply chain knowledge. Mr. Longo has guided the set-up of Prop 215 compliant businesses in California and navigated the complex and multi-layered regulatory environments. Additionally he has years of experience in general cultivation, agriculture, and held various operational roles at Anheuser-Busch Distributors.

Shawn Groshans - Head of Business Development
Shawn Groshans has approximately 20 years in merchant banking and corporate finance with experience in private equity investing, advising companies on mergers and acquisitions, capital raising, business development, and restructuring. Subsequent to his experience in banking he took a role as Head of Business Development for a global intelligence and cyber-security firm, in addition to his involvement in entrepreneurial ventures including the cannabis industry.

Oliver Summers - Director of Retail Dispensaries
Mr. Oliver Summers has been a Los Angeles Medical Cannabis advocate since 2005, speaking and promoting cannabis numerous times on the behalf of patients. He has owned and operated three dispensaries in LA since 2006 and is a Master Cultivator of boutique proprietary cannabis strains. Mr. Summers is an original member and moderator of the Greater Los Angeles Collective Alliance (GLACA), a member of Americans For Safe Access (ASA), Marijuana Policy Project (MPP), Patients Advocacy Network (PAN).

Captor Investments

  • MedMen Santa Ana Dispensary – 100 per cent ownership
  • MedMen West Hollywood Dispensary – 100 per cent ownership
  • Chai (Capitola Healing Association Inc.) – 100 per cent ownership
  • 3863 Hannegan Road, Bellingham, Washington Assets – Owns all LCB approved assets & IP
  • 5873 Guide Meridian, Bellingham, Washington Assets– Owns all LCB approved assets & IP
  • Main Stem Goods and Services – 7.5 per cent ownership

For full details on the above listed investments please download the corporate presentation available to the public at our new website – www.captorcapital.com/news.php.

Grant of Options
Captor announces that yesterday it granted options to Jing Peng (CFO), 500,000 options, to Henry Kloepper (Director), 500,000 options, Alex Dementev (Director), 500,000, Kyle Appleby (Director), 1,000,000, John Macphail (CEO of I-5 Holdings Ltd.) 3 million and 5 million options to Alegana Enterprises Ltd the company through which the services of John Zorbas (CEO) are provided to Captor. In addition the company has awarded stock options to its new employees and consultants that have joined the company, in the aggregated amount 26 million. All stock options are fully vested and exercisable at 30 cents per common share of Captor for a period of 2 years.

Termination of Non-Binding Term Sheet
Captor Capital Corp, announces today that the previously announced non-binding term sheet with leading California cannabis company, Growth Network Holdings, Inc. has mutually been terminate.

About Captor Capital
Captor Capital Corp. is a Canadian firm focused on the cannabis sector listed on the Canadian Securities Exchange, the OTC, and the Frankfurt Stock Exchange. A vertically integrated cannabis investment company, Captor provides recreational and medical marijuana based products to consumers via its leading brands and dispensary locations. Listed on the Canadian Securities Exchange, the OTCUSA, and the Frankfurt Stock Exchange, Captor owns and operates advanced growing facilities which produce consistent high quality contaminant free marijuana for its customers, as well as other high demand cannabis based goods for consumption. The company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis investments including two wholly owned branded MedMen dispensaries – the world famous West Hollywood location and the showpiece Orange County dispensary in Santa Ana. Captor Capital is currently looking at additional revenue generating investments in the cannabis space and will be updating the market in due course.

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

For further information, please contact
Gavin Davidson
Captor Capital Corp.
705.446.6630
gavin@captorcapital.com

Toronto, Ontario – Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR; FRANKFURT:NMV; USOTC:NWURF) today announced that it has agreed to purchase Chai Cannabis Inc. for US$6.1 million in cash and a further US$200,000 to purchase existing inventory at cost. Chai Cannabis currently operates a fully adult use dispensary in Santa Cruz, California. One of the most popular dispensaries in the area, the location averages sales in excess of US$700,000 per month. The company also possesses a license permitting cannabis delivery within the greater Santa Cruz area.

"This investment represents a fantastic growth opportunity for Captor Capital at an extremely reasonable purchase price when Chai's annual revenues are considered," said I-5 Holdings CEO, John MacPhail. "Not only is Chai Cannabis one of the area's leading dispensaries, we feel the Santa Cruz area itself is ripe for further growth. In light of this we are particularly excited about the potential to grow revenues by leveraging the existing delivery license to implement a top quality local delivery service."

For the three years spanning 2014-2017, Chai Cannabis Inc. represented to Captor revenues of approximately US$10 million per year. although revenues took a slight dip in 2017 to US$8.4 million due to the proliferation of newly licensed locations. In 2018 the dispensary has been one of the few in California not to experience a product shortage when the State ushered in a new set of regulations pertaining to the safety and packaging of all cannabis product.

"The fact Chai has not been affected by the state wide product shortage resulting from the new regulations points to strength of the management team and we’re happy that the current management team will remain on board to manage the dispensary," said MacPhail. "We also are confident in our ability to quickly return to, and exceed, previous revenue levels, as the dispensary has never implemented an advertising campaign and has yet to make use of its very valuable delivery license."

The dispensary is also permitted to at least double the size of the showroom which will become at state of the art facility. These renovations are currently underway and are expected to be completed this summer. The newly renovated space will allow Chai to carry a much wider range of flowers, edibles and extracts, further entrenching it’s leadership position in the Santa Cruz market.

"Becoming part of the Captor Capital team represents an exciting new chapter for Chai Cannabis," said dispensary manager, Josh Lechner,. "With a number of exciting investments already in California and a strong executive team, I’m confident Captor has the skills and the knowledge to take Chai to the next level."

About Captor Capital
Captor Capital Corp. is a Canadian investment firm focused on the cannabis sector listed on the Canadian Securities Exchange, the OTC, and the Frankfurt Stock Exchange. The company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis investments including two wholly owned branded MedMen dispensaries – the world famous West Hollywood location and the and the showpiece Orange County dispensary in Santa Ana. Captor Capital is currently looking at additional revenue generating investments in the cannabis space and will be updating the market in due course.

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

Investor contact
John Zorbas, CEO
Captor Capital Corp.
416.504.3978
johnz@captorcapital.com

Media contact
Gavin Davidson, Communications
Captor Capital Corp.
705.446.6630
gavin@captorcapital.com

TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- Captor Capital ("CPTR" or the "Company") (CSE:CPTR) (FRANKFURT:NMV) (OTC:NWURF) announced today that it has decided to change its business focus from a diversified investment and merchant banking company and focus solely on cannabis. This change in the focus and direction of Captor's business is considered a Fundamental Change under Canadian Securities Exchange ("CSE") Policy 8. In accordance with the policies of the CSE, the shareholders of Captor will have to approve this Fundamental Change before it becomes effective.

John Zorbas, President of Captor, stated, "We have made strong investments in the cannabis industry and we are continuing to see great opportunities in cannabis for Captor to exploit in order to deliver value to our shareholders. It just makes sense for us and our shareholders that Captor focuses exclusively on cannabis."

Trading in Captor has been halted and will remain halted at least until the meeting materials to be sent to shareholders for approval of the Fundamental Change have been reviewed and accepted by the CSE and posted to the CSE website. The halt is considered a Regulatory Halt as defined in National Instrument 23-101-Trading Rules.

About Captor Capital
Captor Capital Corp. is a Canadian investment firm listed on the Canadian Securities Exchange and the Frankfurt Stock Exchange. The company follows a strategy of acquiring profitable, established companies and organizations with growth potential that require capital to scale. Captor currently has investments in a number of companies and industries, including Millennial Esports in the technology sector and I-5 Holdings in the cannabis sector.

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

For further information, please contact

John Zorbas, President
Captor Capital Corp.
416.504.3978
Johnz@captorcapital.com

ORONTO, April 09, 2018 (GLOBE NEWSWIRE) -- Captor Capital ("CPTR" or the "Company") (CSE:CPTR) (FRANKFURT:NMV) (OTC:NWURF) announced today that I-5 Holdings Ltd. ("I-5 Holdings") had gross revenues of US$7.57 million (CDN$9.67 million) from its two southern California dispensaries in the three-month period ended March 31, 2018. Captor entered into a definitive purchase agreement to acquire all of the outstanding shares of I-5 on February 16, 2018, the closing of which is in escrow pending the satisfaction of certain outstanding conditions precedent that Captor expects to occur shortly.

"We are now seeing our first investment target in the California cannabis industry produce some very impressive revenue numbers," said Captor President John Zorbas. Mr. Zorbas continued, "Our intention is to continue with our strategic focus of making investments in high-end cannabis retail stores and cultivation facilities in California as demonstrated by Captor's recently announced proposed investment in Growth Network Solutions, which owns two southern California dispensaries, a 45,000 square foot cultivation facility and 29.5 acres of land on which it intends to build a 500,000 square foot cultivation facility."

Founder and CEO of I-5 Holdings John MacPhail said, "We are pleased to see such strong revenue numbers from our dispensaries in the first quarter of recreational cannabis sales in California." Mr. MacPhail added, "I attribute this success to our highly skilled and experienced team at I-5, along with Captor's continued investment support."

About Captor Capital
Captor Capital Corp. is a Canadian investment firm listed on the Canadian Securities Exchange and the Frankfurt Stock Exchange. The company follows a strategy of acquiring profitable, established companies and organizations with growth potential that require capital to scale. Captor currently has investments in a number of companies and industries, including Millennial Esports in the technology sector and I-5 Holdings in the cannabis sector.

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

For further information, please contact
John Zorbas, President
Captor Capital Corp.
416.504.3978
Johnz@captorcapital.com

TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- Captor Capital Corp. ("Captor" or the "Company") (CSE:CPTR) (FRANKFURT:NMV) announced today that it entered into a non-binding term sheet with leading California cannabis company, Growth Network Holdings, Inc. ("Growth Network") to acquire 30 per cent of its issued and outstanding equity securities for a purchase price of US$14,632,500 (the "Investment"). In accordance with the term sheet, Captor will also be granted an option exercisable for up to 12 months after closing to acquire the remaining issued and outstanding equity securities of Growth Network for USD$34,142,500.

Growth Network is a seed to sale cannabis company focusing on cultivation, extraction, distribution and retail sales. Growth Network owns 29.5 acres of land in California City for the purpose of developing a state-of-the-art cannabis business park that will include a cultivation centre with 500,000 square feet of canopy space, making it one of the largest indoor cultivation facilities in California. The cannabis business park, scheduled to break ground in the second quarter of 2018, will also include an extraction and manufacturing facility, a packaging and distribution centre, and an independent testing laboratory. Growth Network also owns and operates a licensed cultivation facility in Los Angeles with 45,000 square feet of indoor cultivation space.

Growth Network also operates two retail dispensaries in the Los Angeles area, including the upscale neighbourhood of Culver City, which is home to corporate offices for Facebook and Sony amongst others. Additionally, Growth Network has three more Los Angeles area dispensaries in the planning stages and expects to open these retail stores sometime in 2018.

"We are very pleased to have reached this agreement in principle with Captor and we are excited to be working with investors that understand not only us and our business, but our market," said Growth Network Solutions founder and CEO, John Jezzini. "By having all of these facilities under one roof, our business park will provide every service required from seed to retail sale," Jezzini continued.

"With our investment and support, Growth Network will be able take full advantage of the incredible assets John Jezzini has built on both the production and retail ends."

Under the terms of the proposed Investment, Captor would acquire the 22.25 per cent of the issued and outstanding equity securities of Growth Network (calculated on a post-purchase basis) from the sole shareholder of Growth Network, John Jezzini, for a purchase price of USD$10,857,500 (the "Share Purchase"). The purchase price will be satisfied in common shares of Captor at a deemed issue price of the lesser of (a) CDN$0.30; and (b) the prevailing market price of Captor shares on the date a definitive share purchase agreement. Captor will also acquire 7.75% per cent the issued and outstanding equity securities of Growth Network directly from treasury for a cash purchase price of USD$3,775,000 (the "Equity Contribution"). After completion of the Share Purchase and the Equity Contribution, Captor will own 30 per cent of Growth Network.

In accordance with the term sheet, John Jezzini, the sole shareholder of Growth Network, will also grant an option to Captor to acquire the remaining issued and outstanding equity securities of Growth Network for USD$34,142,500 for common shares of Captor at a deemed issue price equal to the market price of Captor's common shares at the time the option is exercised. The option shall be exercisable for 12 months and may be extended for a further 12 months if Growth Network has not received all of its remaining cultivation licenses and permits.

Concurrent with the completion of the Share Purchase and the Equity Contribution, Captor will enter into a shareholder agreement with John Jezzini pursuant to which, among other things, Captor will agree to provide debt financing of up to USD$27,875,000 to Growth Network to fund its cultivation and retail dispensary operations. These funds will be lent to Growth Network based on a drawdown schedule conditional upon the achievement of certain milestones to be agreed between Captor and Growth Network.

Upon completion of the Share Purchase, a nominee of Captor will be appointed to the board of directors of Growth Network and, subject to CSE approval, John Jezzini will be added to the board of directors of Captor.

Completion of the Investment is subject to a number of conditions, including but not limited to due diligence and entering into definitive agreements. There can be no assurance that the Investment will be completed on the terms described above or at all.

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

Investor Contact
John Zorbas, President
Captor Capital Corp.
416.504.3978
Johnz@captorcapital.com

TORONTO, ONTARIO -- (Marketwired - Jan. 24, 2018) - Captor Capital Corp. ("Captor" or the "Company") (CSE:CPTR)(CSE:CPTR.CN)(CNSX:CPTR)(FRANKFURT:NMV)(OTC PINK:NWURF) today provided an update on the popularity of the two I-5 Holdings' owned, MedMen branded dispensaries in the Los Angeles area following the legalisation of recreational cannabis in California on January 1, 2018. Captor Capital Inc., I-5 Holdings Ltd.'s largest shareholder, recently announced it has signed a non-binding letter of intent to purchase the remainder of I-5 Holding's shares.

"The success being enjoyed by the MedMen dispensaries in California provide us with a template that is easily scalable," said John MacPhail, CEO, I-5 Holdings. "With more states, as well as Canada, primed to follow California in legalising recreational cannabis, the growth potential for I-5 Holdings is substantial, thanks to its relationship with an established and respected brand like MedMen."

After completion of the amalgamation, I-5 Holdings will be a wholly owned subsidiary of Captor. One of the primary and initial goals of Captor's increased investment in I-5 is to maximise the growth potential of the two I-5 Holdings dispensaries located in the Los Angeles area operating under the MedMen brand.

"Not only will MedMen's Los Angeles dispensaries provide us with brand awareness and a loyal following, they represent a major source of ongoing cash flow," said John Zorbas, President, Captor Capital. "As an investment, this will prove extremely valuable as Captor seeks-out further acquisitions, such as our recent investment in Millennial Esports, and continues to grow."

The dispensaries owned by I-5 Holdings, located in Santa Ana and West Hollywood, are two of seven currently licensed to sell recreational cannabis in the Greater Los Angeles Area. Although recreational cannabis was legalised by the State of California on January 1st, the city of Los Angeles has yet to grant permits for any dispensaries within its borders. As a result, the MedMen dispensaries in West Hollywood and Santa Ana – which were previously licensed to sell medicinal marijuana – are the closest options to buy legal recreational cannabis for the approximately 4 million residents of Los Angeles.

About Captor Capital
Captor Capital Corp. is a Canadian investment firm listed on the Canadian Securities Exchange and the Frankfurt Stock Exchange. The company follows a strategy of acquiring profitable, established companies and organizations with growth potential that require capital to scale. Captor currently has investments in a number of companies and industries, including Millennial Esports in the technology sector, I-5 Holdings in the cannabis sector, and URU Metals in the natural resources sector.

Forward-Looking Statements

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

This press release contains or refers to forward-looking information, and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.

CONTACT INFORMATION
Investor Contact

Captor Capital Corp.
John Zorbas
President
416.504.3978
Johnz@captorcapital.com

Media Contact
Captor Capital Corp.
Gavin Davidson
Communications
705.446.6630
gavin@captorcapital.com